您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > Varespladib Sodium
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Varespladib Sodium
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Varespladib Sodium图片
CAS NO:172733-42-5
包装与价格:
包装价格(元)
100mg电议
250mg电议
500mg电议

产品名称
LY315920 sodium
产品介绍
Varespladib sodium (LY315920 sodium) 是一种有效且具有选择性的group IIA, secretory phospholipase A2(sPLA2)抑制剂,其IC50值为 9 nM。Varespladib sodium 对大鼠,兔,豚鼠和人等各种物种血清的sPLA2活性具有明显的抑制作用,IC50分别为 8.1 nM,5.0 nM,3.2 nM 和 6.2 nM。
生物活性

Varespladib sodium (LY315920 sodium) is a potent and selectivegroup IIA, secretoryphospholipase A2(sPLA2)inhibitor with anIC50of 9 nM. Varespladib sodium exhibits the significant inhibitory effect onsPLA2activity in serum from various species including rat, rabbit, guinea pig and human withIC50s of 8.1 nM, 5.0 nM, 3.2 nM and 6.2 nM, respectively[1].

IC50& Target

sPLA2

9 nM (IC50)

体外研究
(In Vitro)

Varespladib sodium (10 μM; 24 and 48 hours; HCjE cells) treatment results in complete inhibition of the RA-induced increase in MUC16 protein detected in cell lysates at both time points[2].
Varespladib sodium (10 μM; 24 and 48 hours; HCjE cells) treatment significantly inhibits RA-induced MUC16 expression by 100% at 24 hours and 99% at 48 hours[2].

Western Blot Analysis[2]

Cell Line:HCjE cells
Concentration:10 μM
Incubation Time:24 hours, 48 hours
Result:Significantly inhibited the RA-induced MUC16 protein expression at both time points.

RT-PCR[2]

Cell Line:HCjE cells
Concentration:10 μM
Incubation Time:24 hours, 48 hours
Result:Significantly inhibited RA-induced MUC16 expression by 100% at 24 hours and 99% at 48 hours.
体内研究
(In Vivo)

Varespladib sodium treatment inhibits human sPLA2-induced release of thromboxane A2(TXA2) from isolated guinea pig lung bronchoalveolar lavage cells with anIC50of 0.79 μM. And theED50for Varespladib sodium is 16.1 mg/kg[1].

Animal Model:Male Hartley guinea pigs (300-500 g)[1]
Dosage:3 mg/kg, 10 mg/kg, and 30 mg/kg
Administration:Intravenous injection (Pharmacokinetic study)
Result:Consistent inhibition of sPLA2 activity in BAL fluid was observed. Reduced the human sPLA2-induced generation of TXA2 on BAL cells from guinea pigs.
Clinical Trial
分子量

402.38

Formula

C21H19N2NaO5

CAS 号

172733-42-5

中文名称

伐瑞拉迪钠;伐瑞拉地钠

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.